Skip to Main Content

For further information, see CMDT Part 34-08: Adenovirus Infections

KEY FEATURES

  • At least 88 serotypes, which produce a variety of clinical syndromes

  • Usually self-limited or clinically inapparent except in immunosuppressed persons

CLINICAL FINDINGS

  • Common cold

  • Nonstreptococcal exudative pharyngitis

  • Lower respiratory tract infections

  • Pharyngoconjunctival fever

  • Epidemic keratoconjunctivitis

  • Hemorrhagic cystitis

  • Sexually transmitted genitourinary ulcers and urethritis

  • Acute gastroenteritis, mesenteric adenitis, acute appendicitis, rhabdomyolysis, and intussusception

  • Rarely associated with encephalitis, meningitis, cerebellitis, acute respiratory distress syndrome, acute flaccid myelitis, and pericarditis

  • Disseminated disease in transplant recipients

DIAGNOSIS

  • Viral culture is considered the standard

  • Quantitative real-time rapid-cycle polymerase chain reaction (PCR) useful in distinguishing disease from colonization, especially in patients who have received hematopoietic stem cell transplants

  • Multiplex nucleic acid amplification assays can test for multiple respiratory viruses simultaneously with increased sensitivity

  • Appears as a multifocal consolidation or ground-glass opacity without airway inflammatory findings on chest CT imaging

TREATMENT

  • Treatment is symptomatic

  • Immunocompromised patients often treated with ribavirin or cidofovir, with occasional success

    • Cidofovir is attendant with significant renal toxicity and reduction in doses of immunosuppressive agents is often required

  • Brincidofovir, a nucleoside analog

    • Lipid-conjugated prodrug of cidofovir

    • Has better oral bioavailability, is better tolerated, and achieves higher intracellular concentrations of active drug than cidofovir

    • Only available through compassionate use policies

  • Intravenous immunoglobulin (IVIG) is used in immunocompromised persons, but data are still limited

  • Topical steroids or tacrolimus may be used to treat adenoviral keratoconjunctivitis

  • Epidemic adenoviral conjunctivitis is often difficult to control and requires

    • Meticulous attention to hand hygiene

    • Use of disposable gloves

    • Sterilization of equipment (isopropyl alcohol is insufficient, recommendations of manufacturers are preferred)

    • Cohorting of cases

    • Furloughing of employees

    • A combination of povidone-iodine 1.0% eyedrops and dexamethasone 0.1% eyedrops four times a day can reduce symptoms and expedite recovery

  • Vaccines are not available for general use

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.